Read + Share
Amedeo Smart
Independent Medical Education
Li S, Zhang P, Li A, Bao J, et al. Rho-kinase inhibitor alleviates CD4(+)T cell mediated corneal graft rejection by modulating its STAT3 and STAT5 activation. Exp Eye Res 2024 Mar 11:109857. doi: 10.1016/j.exer.2024.109857.PMID: 38479724
Email
LinkedIn
Facebook
Twitter
Privacy Policy